Carter Todd Alfred
SEC insider (Form 3/4/5 filer). CIK 0001944011. Chief Scientific Officer at Voyager Therapeutics, Inc. (VYGR). 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 24, 2026. Located in LEXINGTON, MA.
Companies Carter Todd Alfred has filed insider reports for
- Voyager Therapeutics, Inc. (VYGR): Officer, Chief Scientific Officer
Carter Todd Alfred
CIK: 0001944011
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Voyager Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Feb 24, 2026VYGR
Voyager Therapeutics, Inc.
SaleDirect4.2K shares at avg. $3.76$16K - Feb 18, 2026VYGR
Voyager Therapeutics, Inc.
SaleDirect3.3K shares at avg. $3.44$11K - Feb 10, 2026VYGR
Voyager Therapeutics, Inc.
SaleDirect3.5K shares at avg. $3.85$14K - Feb 6, 2026VYGR
Voyager Therapeutics, Inc.
AwardDirect33K shares- - Feb 21, 2025VYGR
Voyager Therapeutics, Inc.
AwardDirect46K shares- - Feb 20, 2025VYGR
Voyager Therapeutics, Inc.
SaleDirect3.3K shares at avg. $4.26$14K - Feb 11, 2025VYGR
Voyager Therapeutics, Inc.
SaleDirect5.4K shares at avg. $4.45$24K - Jan 14, 2025VYGR
Voyager Therapeutics, Inc.
SaleDirect1.2K shares at avg. $5.13$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 24, 2026 | VYGR Voyager Therapeutics, Inc. | Sale | 4,174 | $3.76 | $15,694 | Direct |
| Feb 18, 2026 | VYGR Voyager Therapeutics, Inc. | Sale | 3,301 | $3.44 | $11,355 | Direct |
| Feb 10, 2026 | VYGR Voyager Therapeutics, Inc. | Sale | 3,525 | $3.85 | $13,571 | Direct |
| Feb 6, 2026 | VYGR Voyager Therapeutics, Inc. | Award | 33,000 | - | $0 | Direct |
| Feb 21, 2025 | VYGR Voyager Therapeutics, Inc. | Award | 46,000 | - | - | Direct |
| Feb 20, 2025 | VYGR Voyager Therapeutics, Inc. | Sale | 3,305 | $4.26 | $14,079 | Direct |
| Feb 11, 2025 | VYGR Voyager Therapeutics, Inc. | Sale | 5,413 | $4.45 | $24,088 | Direct |
| Jan 14, 2025 | VYGR Voyager Therapeutics, Inc. | Sale | 1,191 | $5.13 | $6,110 | Direct |
1-8 of 8 transactions